Trials / Completed
CompletedNCT07535424
Comparative Efficacy of Topical Clotrimazole Versus 2% Salicylic Acid in Otomycosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Mayo Hospital Lahore · Academic / Other
- Sex
- All
- Age
- 5 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Otomycosis is a fungal infection of the outer ear canal that commonly causes itching, discomfort, discharge, and a feeling of blockage in the ear. This randomized controlled study was conducted to compare two commonly used topical treatments for otomycosis: clotrimazole ear drops and 2% salicylic acid ear drops. A total of 60 patients diagnosed with otomycosis were enrolled and were randomly assigned in equal numbers to one of the two treatment groups. One group received clotrimazole drops three times daily for two weeks, while the other group received 2% salicylic acid drops at the same frequency and for the same duration. Patients were assessed at the start of treatment and again after two weeks. The main outcome measure was relief of ear blockage, which reflected improvement in canal patency after treatment. It was hypothesized that topical clotrimazole would be more effective than 2% salicylic acid in clearing ear blockage and improving short-term clinical recovery in patients with otomycosis. This study was conducted to provide evidence for selecting an effective, practical, and affordable topical treatment for routine clinical use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | clotrimazole | Three drops of clotrimazole were administered in the affected ear three times daily for two weeks. |
| DRUG | 2% Salicylic Acid | Three drops of 2% salicylic acid were administered in the affected ear three times daily for two weeks. |
Timeline
- Start date
- 2024-11-20
- Primary completion
- 2025-10-20
- Completion
- 2025-10-20
- First posted
- 2026-04-17
- Last updated
- 2026-04-17
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT07535424. Inclusion in this directory is not an endorsement.